| Dynamics and genomic landscape of CD8+ T cells undergoing hepatic priming AP Bénéchet, G De Simone, P Di Lucia, F Cilenti, G Barbiera, N Le Bert, ... Nature 574 (7777), 200-205, 2019 | 203 | 2019 |
| A subset of Kupffer cells regulates metabolism through the expression of CD36 C Blériot, E Barreby, G Dunsmore, R Ballaire, S Chakarov, X Ficht, ... Immunity 54 (9), 2101-2116. e6, 2021 | 158 | 2021 |
| Identification of a Kupffer cell subset capable of reverting the T cell dysfunction induced by hepatocellular priming G De Simone, F Andreata, C Bleriot, V Fumagalli, C Laura, ... Immunity 54 (9), 2089-2100. e8, 2021 | 116 | 2021 |
| Administration of aerosolized SARS-CoV-2 to K18-hACE2 mice uncouples respiratory infection from fatal neuroinvasion V Fumagalli, M Ravŕ, D Marotta, P Di Lucia, C Laura, E Sala, M Grillo, ... Science Immunology 7 (67), eabl9929, 2021 | 84 | 2021 |
| SARS-CoV-2 infection induces DNA damage, through CHK1 degradation and impaired 53BP1 recruitment, and cellular senescence U Gioia, S Tavella, P Martínez-Orellana, G Cicio, A Colliva, M Ceccon, ... Nature Cell Biology 25 (4), 550-564, 2023 | 77 | 2023 |
| COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models A Conforti, E Marra, F Palombo, G Roscilli, M Ravŕ, V Fumagalli, A Muzi, ... Molecular Therapy 30 (1), 311-326, 2022 | 66 | 2022 |
| Effector CD8+ T cell-derived interleukin-10 enhances acute liver immunopathology J Fioravanti, P Di Lucia, D Magini, F Moalli, C Boni, AP Benechet, ... Journal of hepatology 67 (3), 543-548, 2017 | 55 | 2017 |
| Serum HBsAg clearance has minimal impact on CD8+ T cell responses in mouse models of HBV infection V Fumagalli, P Di Lucia, V Venzin, EB Bono, R Jordan, CR Frey, ... Journal of Experimental Medicine 217 (11), e20200298, 2020 | 44 | 2020 |
| Group 1 ILCs regulate T cell–mediated liver immunopathology by controlling local IL-2 availability V Fumagalli, V Venzin, P Di Lucia, F Moalli, X Ficht, G Ambrosi, L Giustini, ... Science immunology 7 (68), eabi6112, 2022 | 28 | 2022 |
| Protective immune trajectories in early viral containment of non-pneumonic SARS-CoV-2 infection K Pekayvaz, A Leunig, R Kaiser, M Joppich, S Brambs, A Janjic, O Popp, ... Nature Communications 13 (1), 1018, 2022 | 25 | 2022 |
| Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination V Fumagalli, M Ravŕ, D Marotta, P Di Lucia, EB Bono, L Giustini, ... Nature Immunology 25 (4), 633-643, 2024 | 23 | 2024 |
| Update on enantiomeric composition of (1 R)-(+)-and (1 S)-(–)-camphor in essential oils by enantioselective gas chromatography F Tateo, M Bononi, E De Dominicis, V Fumagalli Analytical Communications 36 (4), 149-151, 1999 | 22 | 1999 |
| Nirmatrelvir treatment of SARS‐CoV‐2‐infected mice blunts antiviral adaptive immune responses V Fumagalli, P Di Lucia, M Ravŕ, D Marotta, E Bono, S Grassi, L Donnici, ... EMBO molecular medicine 15 (5), e17580, 2023 | 19 | 2023 |
| Isolation of mouse Kupffer cells for phenotypic and functional studies F Andreata, C Blériot, P Di Lucia, G De Simone, V Fumagalli, X Ficht, ... STAR protocols 2 (4), 100831, 2021 | 18 | 2021 |
| Pyrimidine de novo synthesis inhibition selectively blocks effector but not memory T cell development S Scherer, SG Oberle, K Kanev, AK Gerullis, M Wu, GP de Almeida, ... Nature immunology 24 (3), 501-515, 2023 | 13 | 2023 |
| CD8 cis-targeted IL-2 drives potent antiviral activity against hepatitis B virus F Andreata, KD Moynihan, V Fumagalli, P Di Lucia, DC Pappas, ... Science Translational Medicine 16 (729), eadi1572, 2024 | 9 | 2024 |
| Immunogenicity and pre-clinical efficacy of an OMV-based SARS-CoV-2 vaccine A Grandi, M Tomasi, I Ullah, C Bertelli, T Vanzo, S Accordini, A Gagliardi, ... Vaccines 11 (10), 1546, 2023 | 9 | 2023 |
| Therapeutic potential of co-signaling receptor modulation in hepatitis B F Andreata, C Laura, M Ravŕ, CC Krueger, X Ficht, K Kawashima, ... Cell, 2024 | 7 | 2024 |
| Preclinical evaluation of therapeutic vaccines for chronic hepatitis B that stimulate antiviral activities of T cells and NKT cells AH Mooney, SL Draper, OK Burn, RJ Anderson, BJ Compton, C Tang, ... JHEP Reports 6 (5), 101038, 2024 | 7 | 2024 |
| The interplay of drug therapeutics and immune responses to SARS-CoV-2 V Fumagalli, M Iannacone Cellular & Molecular Immunology 21 (2), 197-200, 2024 | 7 | 2024 |
